1. Executive Summary

Three-sentence thesis. ServiceNow is the dominant enterprise workflow-automation platform — the system of action that sits on top of a company's systems of record — compounding revenue at 20%+ with a 98% renewal rate, a 34% free-cash-flow margin, and $28.2B of contracted-but-unrecognized backlog (RPO). The stock has fallen ~52% from its January-2025 peak ($234 split-adjusted) to ~$112, a drawdown driven not by a business stumble but by multiple compression in high-multiple software plus fear that AI commoditizes application software — yet ServiceNow's own AI product (Now Assist) just crossed $600M ACV and is being raised toward $1.5B, demonstrating that AI is a tailwind for this platform, not a threat. At ~25x trailing free cash flow and a reverse-DCF-implied growth rate of only ~14% against a business compounding FCF north of 20%, the market is extrapolating a deceleration that the contracted backlog and AI attach data contradict; this is a high-quality compounder on sale, though not yet at a margin of safety wide enough for a back-up-the-truck buy.

Metrics dashboard (all per-share figures post-split):

Verdict: ACCUMULATE on weakness, target 2-4% allocation. Fair value ~$135-140 (range $115-160). At $112 there is ~15-20% upside to base-case intrinsic value — enough for a quality compounder with a 98% renewal moat, but not the 30%+ margin of safety I demand without a catalyst. I would start a position here and add aggressively below $95 (Strong Buy ~$92, Accumulate ~$108).

2. Phase 0 — Opportunity Identification (Klarman: why is it cheap?)

A great business is rarely cheap without a reason. Here the reasons are identifiable and, I believe, temporary:

Conclusion. The opportunity exists because the market is repricing future growth multiples on a fear (AI displacement) that the company's current monetization data (Now Assist ACV) directly refutes. The dislocation is between the stock's multiple and the business's fundamentals, not within the business itself. That is precisely the kind of gap a patient owner-investor wants — and exactly what Chuck Akre, who built a 40-year record buying "compounding machines" run by able, honest people at reasonable prices, appears to have acted on.

3. Business Quality — Quick Screen

Can I explain it in one sentence? Yes: ServiceNow sells a subscription cloud platform that lets large organizations digitize and automate their internal workflows — IT service management, HR, customer service, security, and increasingly AI "agents" — so work flows across departments the way an operating system routes tasks across a computer.

NOW passes the quality screen decisively on a cash basis. The one caveat — GAAP ROE below Buffett's 15% bar — is an artifact of (a) heavy stock-based compensation depressing net income and (b) a fortress balance sheet that inflates the equity denominator. On the economics that matter (cash generation per dollar of invested capital), this is a top-decile business.

4. Phase 1 — Risk Analysis (Inversion)

"All I want to know is where I'm going to die, so I'll never go there." — Munger

4.1 Risk register (probability x impact)

4.2 The inversion questions

How could this lose 50%+ permanently? The only path is Risk #1 compounding with Risk #2: agentic AI lets enterprises build their own workflow automation cheaply (or buy it bundled "for free" from Microsoft/Salesforce), ServiceNow's seat-based pricing erodes as headcount-linked revenue shrinks, net-new ACV stalls, the 98% renewal rate finally cracks below 90%, and the market re-rates a no-growth software utility to ~12-15x FCF. That is a coherent bear case — and the reason I will not pay up.

What would make me sell immediately (non-price triggers)?

1. Renewal rate falls below ~95% for two consecutive years (moat crack).
2. Net-new ACV growth turns negative for two consecutive quarters (demand break).
3. Now Assist ACV growth stalls or reverses (AI thesis falsified).
4. A major, value-destructive acquisition (>$5B) that abandons the organic-compounder model.
5. McDermott departs and the platform-expansion cadence visibly slows.

The 3-sentence bear case (stated better than the bears): ServiceNow's revenue is still substantially tied to enterprise seat counts, and agentic AI is the first technology in two decades that credibly reduces the number of seats — so the very AI wave bulls cite as a tailwind may, after a transition period, shrink the denominator NOW prices against. At 25x FCF the stock still embeds high-teens growth in perpetuity, leaving no margin for the deceleration that the law of large numbers makes nearly inevitable on a $14B base. And ServiceNow sits in the crosshairs of the three best-capitalized software companies on earth — Microsoft, Salesforce, SAP — all of whom can bundle "good-enough" workflow AI into suites the customer already pays for.

Can I rebut it? Partly. The seat-pricing concern is real, but management is explicitly moving to consumption / non-seat-based pricing (half of net-new business in Q1'26 ran on usage-based models), which converts the AI-eats-seats risk into an AI-grows-consumption tailwind. The competitive concern is mitigated by ServiceNow's deliberate neutrality — it orchestrates work across Microsoft, Salesforce, and SAP rather than competing inside any one stack — which is exactly why customers with 15+ disparate systems standardize on it. The valuation concern is the one I respect most, and it is why this is an Accumulate, not a Strong Buy.

5. Phase 2 — Financial Analysis

5.1 DuPont ROE decomposition (GAAP, 5-year)

Reading it correctly. The 2023 spike (19.3% net margin) reflects a one-time deferred-tax valuation-allowance release (negative effective tax rate that year), not operating improvement. The "real" GAAP net margin is 13%, held down by ~$2.0B of annual stock-based compensation (15% of revenue). Leverage is falling (2.92 -> 2.01) as equity compounds — the opposite of a company juicing ROE with debt. The right conclusion: GAAP ROE understates economic returns; this is a cash machine wearing a low-net-income mask.

5.2 Owner earnings and free cash flow

The chasm between net income ($1.75B) and OCF ($5.44B) in 2025 is the SaaS signature: ~$2.0B SBC (a non-cash GAAP expense, but a real dilution cost) plus growth in deferred revenue (cash collected up front for services delivered later). FCF margin expanding through 30% -> 34.5% while revenue more than doubled is the hallmark of operating leverage on a fixed-cost platform.

Owner earnings (Buffett definition, conservative): I haircut FCF by 20% to charge shareholders for SBC dilution as a real economic cost:

Owner earnings ~ TTM FCF x (1 - 0.20) = $4.63B x 0.80 = $3.70B
Owner earnings per share ~ $3.70B / 1.04B = $3.56

Even on this stingy, dilution-charged basis the business earns $3.56/share — a ~3.2% owner-earnings yield at $112, for an asset growing the numerator >15%/yr.

5.3 ROIC vs WACC

WACC estimate: beta 0.93, equity risk premium ~5%, risk-free ~4.3% -> cost of equity ~9%; near-zero net debt -> WACC ~9-9.5%. **ROIC (22%) - WACC (~9.5%) ~ +12.7 points of positive spread.** Every incremental dollar ServiceNow reinvests in R&D and go-to-market earns roughly double its cost of capital — the defining trait of a value-creating compounder.

5.4 Valuation Trinity

(a) Liquidation / floor value. Not meaningful for an asset-light software business — tangible book is small relative to price, and the value is the contracted backlog and customer relationships, not hard assets. NCAV is negative (current liabilities, mostly deferred revenue, exceed current assets — but deferred revenue is a good liability representing pre-paid future revenue). The floor here is the franchise value of $28.2B RPO at a 98% renewal rate, not balance-sheet assets.

(b) Going-concern DCF (my own assumptions). Two-stage, on owner earnings ($3.70B base), $3.9B net cash added, 1.04B shares:

Reverse DCF reality check. Solving for the growth that justifies $112.45 (10% discount, 4% terminal): the market is implying only ~14% stage-1 owner-earnings growth. ServiceNow grew revenue 22% last quarter, raised 2026 subscription guidance to +20.5-21%, and carries a backlog growing 23.5%. The market's implied 14% is a deceleration assumption the data does not yet support — that gap is the thesis.

(c) Exit-multiple cross-check. Forward FCF ~$5.56B (+20%). ServiceNow has historically traded 30-45x FCF; I use a normalized, de-rated 25-28x:

• 25x fwd FCF + net cash -> $137/share
• 28x fwd FCF + net cash -> $153/share

(d) Owner-earnings multiple. At 30-35x the dilution-charged $3.56 OE/share -> $107-125/share.

Triangulation -> intrinsic value ~$135-140, range $115-160.

5.5 Margin of safety

At $112.45 against a ~$137 weighted IV, MOS ~ 18%. That clears the "20% with catalyst" bar only loosely; without a hard near-term catalyst my framework wants 30%. The Now Assist monetization ramp is a soft catalyst (re-accelerating ACV could re-rate the multiple), which is why I land on Accumulate rather than Wait.

6. Phase 3 — Moat Analysis

6.1 Moat sources and metrics

Switching-cost math. A large enterprise embeds ServiceNow into hundreds of automated workflows and integrations. The cost to switch — re-platforming processes, retraining, integration risk, and operational downtime — dwarfs the annual subscription. With ACV often in the millions and switching cost a large multiple of one year's fee, the rational customer renews. The 98% renewal rate is the empirical proof: only ~2% of the base leaves annually, and most "loss" is account merging, not defection (per the 10-K).

6.2 Moat durability (erosion forces)

Will the moat be wider or narrower in 10 years? I judge it modestly wider. The risk is real (agentic AI is genuinely disruptive), but ServiceNow is positioned as the beneficiary: the more autonomous AI agents an enterprise deploys, the more it needs a neutral control plane to govern, route, and audit them — which is precisely what ServiceNow is building. The renewal rate and AI-attach data support a widening, not narrowing, moat. Verdict: Wide moat, Widening trend.

7. Phase 4 — Management & Incentives

Munger's question — "if I were management with these incentives, what would I do?" Reinvest in the platform to widen the moat and grow the per-share cash machine, exactly what they are doing. The one watch-item is SBC: at ~$2.0B/year it is a real transfer from shareholders to employees, and I want to see buybacks continue to neutralize the dilution.

8. Phase 5 — Catalysts

No-catalyst note. Even absent a single catalyst, a business compounding owner earnings at ~15-20% will, over a 3-5 year hold, grow into and past today's price — but the soft catalysts above (especially AI monetization) materially raise the probability of multiple re-rating, shortening the wait.

9. Phase 6 — Decision Synthesis

9.1 Expected-return probability tree (3-year horizon)

The skew is favorable: a ~+26% three-year expected return with a heavy 70% probability mass on positive outcomes, and a disaster case that, while painful, is low-probability given the contracted RPO and renewal data.

9.2 Position sizing

Quality is top-decile (A grade), moat is wide and widening, but margin of safety is only ~18% and there is genuine AI-disruption tail risk. That argues for a starter-to-standard position now (2%), scaling to 3-4% on a deeper drawdown (sub-$95). This is a "buy quality on a dip, add on a bigger dip" posture, not an all-in.

9.3 Entry prices

Weighted intrinsic value (IV):     ~$137
Strong Buy   (IV x 0.67, 33% MOS): ~$92
Buy/Accumulate (IV x 0.80, 20%):   ~$108-110
Fair value:                         ~$137
Take profits (IV x 1.20):           ~$164
Sell        (IV x 1.50):            ~$205

Current $112 sits just above the Accumulate line — a reasonable place to begin, with conviction rising materially below $95-100.

9.4 Monitoring metrics

10. Psychology Check (Munger) and the Superinvestor Signal

Am I anchoring on the price drop (deprival/availability bias)? Partly — a 45% drawdown is what put NOW on the screen. I counter this by valuing the business absolutely (DCF, owner earnings, reverse DCF), not relative to its old $234 high. On those absolute measures it is moderately undervalued, which is a different and more defensible reason to buy than "it fell a lot."

Social proof — am I buying because Akre bought? Chuck Akre's 40-year record is built on exactly this profile: high-ROIC compounders with reinvestment runways and able management ("the three-legged stool" — business, management, reinvestment). His new ~1.87% NOW position is a meaningful confirmation that an independent, disciplined mind sees the same compounding machine at a now-reasonable price. But I reached the Accumulate verdict from my own DCF and moat work; Akre's signal raises my confidence, it does not constitute my thesis. I would not own this if my own numbers said otherwise.

The final inversion. If NOW dropped 50% tomorrow to ~$56 with the renewal rate still 98% and Now Assist still ramping, I would be a buyer, not a seller — the mark of a thesis grounded in the business rather than the quote. That is the test that converts this from a momentum bounce-watch into a genuine value opportunity.

11. Final Recommendation

+-----------------------------------------------------------------+
|                     INVESTMENT RECOMMENDATION                   |
+-----------------------------------------------------------------+
| Company: ServiceNow, Inc.            Ticker: NOW (NYSE)         |
| Current Price: $112.45               Date: 2026-06-06           |
+-----------------------------------------------------------------+
| VALUATION SUMMARY                                               |
|   DCF (base, 18%/10%/4%/10%) ...... $139   (+24%)               |
|   DCF (bear) ...................... $90    (-20%)               |
|   DCF (bull) ...................... $179   (+59%)               |
|   Exit 25-28x fwd FCF ............. $137-153                    |
|   Owner earnings 30-35x ........... $107-125                   |
|                                                                 |
|   INTRINSIC VALUE ESTIMATE: ~$137 (weighted)                   |
|   MARGIN OF SAFETY @ $112.45: ~18%                             |
+-----------------------------------------------------------------+
| RECOMMENDATION:  ACCUMULATE (starter now, add on weakness)     |
+-----------------------------------------------------------------+
| STRONG BUY:     ~$92  (33% MOS)                                |
| ACCUMULATE:     ~$108-110 (20% MOS)                            |
| FAIR VALUE:     ~$137                                           |
| TAKE PROFITS:   ~$164                                           |
| SELL:           ~$205                                           |
+-----------------------------------------------------------------+
| POSITION SIZE: 2% starter, scale to 3-4% sub-$95               |
| CATALYST: Now Assist AI monetization ($0.6B -> $1.5B ACV)      |
| PRIMARY RISK: Agentic AI commoditizing application software    |
| SELL TRIGGER: Renewal rate <95% (2yr) or net-new ACV negative  |
+-----------------------------------------------------------------+

Bottom line. ServiceNow is a wide-moat, 20%-growing, 34%-FCF-margin compounding machine that the market has put on sale over an AI fear its own data refutes. At $112 it is moderately undervalued (18% to a ~$137 base case) — good enough to begin accumulating a quality business, with the discipline to add far more aggressively below $95-100. Akre's new position is a credible second opinion on the same thesis. Accumulate.

12. Sources

All figures post the 5-for-1 stock split effective 2025-12-17. Independent analysis; no analyst price targets used as inputs.